118 related articles for article (PubMed ID: 32822079)
1. Sensitive identification of prostate-specific antigen by iron oxide nanoparticle antibody conjugates on the gap-finger electrode surface.
Zhang W; Li K; Guo J; Ma T; Wang D; Shi S; Gopinath SCB; Gu D
Biotechnol Appl Biochem; 2021 Aug; 68(4):896-901. PubMed ID: 32822079
[TBL] [Abstract][Full Text] [Related]
2. Ultrasensitive electrochemical immunosensor for PSA biomarker detection in prostate cancer cells using gold nanoparticles/PAMAM dendrimer loaded with enzyme linked aptamer as integrated triple signal amplification strategy.
Kavosi B; Salimi A; Hallaj R; Moradi F
Biosens Bioelectron; 2015 Dec; 74():915-23. PubMed ID: 26257183
[TBL] [Abstract][Full Text] [Related]
3. Graphene oxide layer decorated gold nanoparticles based immunosensor for the detection of prostate cancer risk factor.
Pal M; Khan R
Anal Biochem; 2017 Nov; 536():51-58. PubMed ID: 28789963
[TBL] [Abstract][Full Text] [Related]
4. An electrochemical immunosensor for the prostate specific antigen based on the use of reduced graphene oxide decorated with gold nanoparticles.
Assari P; Rafati AA; Feizollahi A; Asadpour Joghani R
Mikrochim Acta; 2019 Jun; 186(7):484. PubMed ID: 31256262
[TBL] [Abstract][Full Text] [Related]
5. Construction of novel electrochemical immunosensor for detection of prostate specific antigen using ferrocene-PAMAM dendrimers.
Çevik E; Bahar Ö; Şenel M; Abasıyanık MF
Biosens Bioelectron; 2016 Dec; 86():1074-1079. PubMed ID: 27641479
[TBL] [Abstract][Full Text] [Related]
6. Determination of the percentage of free prostate-specific antigen helps to avoid unnecessary biopsies in men with normal rectal examinations and total prostate-specific antigen of 4-10 ng/ml.
Martínez-Piñeiro L; Tabernero A; Contreras T; Madero R; Lozano D; López-Tello J; Alonso-Dorrego JM; Picazo ML; González Gancedo P; Martínez-Piñeiro JA; de La Peña JJ
Eur Urol; 2000 Mar; 37(3):289-96. PubMed ID: 10720854
[TBL] [Abstract][Full Text] [Related]
7. An immunosensing device based on inhibition of mediator's faradaic process for early diagnosis of prostate cancer using bifunctional nanoplatform reinforced by carbon nanotube.
Farzin L; Sadjadi S; Shamsipur M; Sheibani S
J Pharm Biomed Anal; 2019 Aug; 172():259-267. PubMed ID: 31078062
[TBL] [Abstract][Full Text] [Related]
8. Detection of early stage prostate cancer by using a simple carbon nanotube@paper biosensor.
Ji S; Lee M; Kim D
Biosens Bioelectron; 2018 Apr; 102():345-350. PubMed ID: 29172142
[TBL] [Abstract][Full Text] [Related]
9. An electrochemical biosensor to simultaneously detect VEGF and PSA for early prostate cancer diagnosis based on graphene oxide/ssDNA/PLLA nanoparticles.
Pan LH; Kuo SH; Lin TY; Lin CW; Fang PY; Yang HW
Biosens Bioelectron; 2017 Mar; 89(Pt 1):598-605. PubMed ID: 26868935
[TBL] [Abstract][Full Text] [Related]
10. Highly sensitive immunosensing of prostate-specific antigen based on ionic liquid-carbon nanotubes modified electrode: application as cancer biomarker for prostate biopsies.
Salimi A; Kavosi B; Fathi F; Hallaj R
Biosens Bioelectron; 2013 Apr; 42():439-46. PubMed ID: 23235113
[TBL] [Abstract][Full Text] [Related]
11. Wisteria floribunda Agglutinin and Its Reactive-Glycan-Carrying Prostate-Specific Antigen as a Novel Diagnostic and Prognostic Marker of Prostate Cancer.
Hagiwara K; Tobisawa Y; Kaya T; Kaneko T; Hatakeyama S; Mori K; Hashimoto Y; Koie T; Suda Y; Ohyama C; Yoneyama T
Int J Mol Sci; 2017 Jan; 18(2):. PubMed ID: 28134773
[No Abstract] [Full Text] [Related]
12. Biosensing of prostate specific antigen (PSA) in human plasma samples using biomacromolecule encapsulation into KCC-1-npr-NH
Abbasy L; Mohammadzadeh A; Hasanzadeh M; Ehsani M; Mokhtarzadeh A
Int J Biol Macromol; 2020 Jul; 154():584-595. PubMed ID: 32173432
[TBL] [Abstract][Full Text] [Related]
13. [PSA and hK2 in the diagnosis of prostate cancer].
Alapont Alacreu JM; Navarro Rosales S; Budía Alba A; España Furió F; Morera Martínez F; Jiménez Cruz JF
Actas Urol Esp; 2008 Jun; 32(6):575-88. PubMed ID: 18655340
[TBL] [Abstract][Full Text] [Related]
14. Impedimetric PSA aptasensor based on the use of a glassy carbon electrode modified with titanium oxide nanoparticles and silk fibroin nanofibers.
Benvidi A; Banaei M; Tezerjani MD; Molahosseini H; Jahanbani S
Mikrochim Acta; 2017 Dec; 185(1):50. PubMed ID: 29594398
[TBL] [Abstract][Full Text] [Related]
15. A retrospective and prospective overview of prostate-specific antigen.
Ablin RJ
J Cancer Res Clin Oncol; 1997; 123(11-12):583-94. PubMed ID: 9620215
[TBL] [Abstract][Full Text] [Related]
16. Detection of prostate-specific antigen- or prostate-specific membrane antigen-positive circulating cells in prostatic cancer patients: clinical implications.
Millon R; Jacqmin D; Muller D; Guillot J; Eber M; Abecassis J
Eur Urol; 1999 Oct; 36(4):278-85. PubMed ID: 10473985
[TBL] [Abstract][Full Text] [Related]
17. SERS-Based Pump-Free Microfluidic Chip for Highly Sensitive Immunoassay of Prostate-Specific Antigen Biomarkers.
Gao R; Lv Z; Mao Y; Yu L; Bi X; Xu S; Cui J; Wu Y
ACS Sens; 2019 Apr; 4(4):938-943. PubMed ID: 30864786
[TBL] [Abstract][Full Text] [Related]
18. Clinical usefulness of free PSA fraction as an indicator of prostate cancer.
Filella X; Alcover J; Molina R; Giménez N; Rodríguez A; Jo J; Carretero P; Ballesta AM
Int J Cancer; 1995 Dec; 63(6):780-4. PubMed ID: 8847133
[TBL] [Abstract][Full Text] [Related]
19. The use of serum zinc to prostate-specific antigen ratio as a biomarker in the prediction of prostate biopsy outcomes.
Temiz MZ; Cakir OO; Aykan S; Kucuk SH; Tiryakioglu NO; Bilek G; Tunali NE; Kandirali E; Semercioz A
Biomark Med; 2019 Feb; 13(2):59-68. PubMed ID: 30672309
[TBL] [Abstract][Full Text] [Related]
20. How to use prostate-specific antigen.
Ploch NR; Brawer MK
Urology; 1994 Feb; 43(2 Suppl):27-35. PubMed ID: 7509534
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
